^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BTG-002814
i
Other names: BTG-002814, vandetanib-eluting radiopaque beads
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Boston Scientific, UCL Cancer Institute
Drug class:
RET inhibitor, VEGFR-2 inhibitor, EGFR antagonist
Related drugs:
